If any controlled substance appears in the listed bulk database, please ignore it, as we do not supply or offer controlled substances.
Quetiapine EP Impurity N
100% accuracy
of data
24/7 scientific
support
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

1800291-86-4Quetiapine EP Impurity N

● In Stock

Catalogue No.:VE009091
CAS No.:1800291-86-4
Mol. Formula:C29H41N5O3S
Mol. Weight:539.73 g/mol

Additional information on CAS 1800291-86-4

Parent drug

Quetiapine

IUPAC Name

2-(2-(4-(2-(2-(4-(Dibenzo[b,f][1,4]thiazepin-11-yl)piperazin-1-yl)ethoxy)ethyl)piperazin-1-yl)ethoxy)ethanol

Synonyms

Quetiapine Dipiperazine Diether Impurity

Smiles

OCCOCCN1CCN(CCOCCN(CC2)CCN2C3=NC(C=CC=C4)=C4SC5=C3C=CC=C5)CC1

Description

Quetiapine EP Impurity N, also described as quetiapine dipiperazine diether impurity (free base), is a process-related structural variant of the dibenzothiazepine antipsychotic scaffold rather than a simple degradation product. CAS 1800291-86-4; molecular formula C29H41N5O3S; molecular weight 539.73 g/mol. The name indicates ether-linked dipiperazine substitution, consistent with alkylation or overreaction during synthesis or intermediate handling. Such impurities are typically monitored by reversed-phase LC with diode-array or LC-MS/MS confirmation, and may require high-resolution MS for trace characterization. Although not a classical genotoxic alert, its presence is assessed under impurity control and specification frameworks.

Request a Quote

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
This field is hidden when viewing the form
Products quotation
Name
Url
 
This field is hidden when viewing the form
This field is hidden when viewing the form